학술논문
Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies
Document Type
Article
Author
Parisi, A.; Delaunay, B.; Pinterpe, G.; Giampieri, R.; Berardi, R.; Fares, N.; Hollebecque, A.; Blanc, J.F.; Bouattour, M.; Assenat, E.; Ben Abdelghani, M.; Sarabi, M.; Artru, P.; Niger, M.; Vivaldi, C.; Mandalà, M.; Palloni, A.; Bensi, M.; Garattini, S.K.; Tougeron, D.; Combe, P.; Salati, M.; Rimini, M.; Cella, C.A.; Tucci, M.; Diana, A.; Mori, E.; Longarini, R.; Roth, G.; Evesque, L.; Vienne, A.; Turpin, A.; Hiret, S.; Bourgeois, V.; Herve, C.; Paulon, R.; Stacoffe, M.; Malka, D.; Neuzillet, C.; Edeline, J.; Lievre, A.; Guimbaud, R.; Chapda, M.C.P.; Rimassa, L.; Valle, J.
Source
In: European Journal of Cancer . (European Journal of Cancer, March 2024, 200)
Subject
Language
English
ISSN
18790852
09598049
09598049